These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8836298)

  • 21. [Presynaptic nigrostriatal function in Parkinson disease and Parkinson-plus syndromes. Comparative studies using positron emission tomography with L-6-(18F)fluorodopa].
    Cordes M; Poewe W
    Nervenarzt; 1994 Oct; 65(10):696-9. PubMed ID: 7808568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional changes in [18F]dopa metabolism in the striatum in Parkinson's disease.
    Morrish PK; Sawle GV; Brooks DJ
    Brain; 1996 Dec; 119 ( Pt 6)():2097-103. PubMed ID: 9010013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemispheric Network Expression in Parkinson's Disease: Relationship to Dopaminergic Asymmetries.
    Tang CC; Holtbernd F; Ma Y; Spetsieris P; Oh A; Fink GR; Timmermann L; Eggers C; Eidelberg D
    J Parkinsons Dis; 2020; 10(4):1737-1749. PubMed ID: 32925097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Young-onset Parkinson disease with and without parkin gene mutations: a fluorodopa F 18 positron emission tomography study.
    Thobois S; Ribeiro MJ; Lohmann E; Dürr A; Pollak P; Rascol O; Guillouet S; Chapoy E; Costes N; Agid Y; Remy P; Brice A; Broussolle E;
    Arch Neurol; 2003 May; 60(5):713-8. PubMed ID: 12756135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blinded positron emission tomography study of dopamine cell implantation for Parkinson's disease.
    Nakamura T; Dhawan V; Chaly T; Fukuda M; Ma Y; Breeze R; Greene P; Fahn S; Freed C; Eidelberg D
    Ann Neurol; 2001 Aug; 50(2):181-7. PubMed ID: 11506400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography.
    Eidelberg D; Moeller JR; Ishikawa T; Dhawan V; Spetsieris P; Chaly T; Belakhlef A; Mandel F; Przedborski S; Fahn S
    Neurology; 1995 Nov; 45(11):1995-2004. PubMed ID: 7501148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolated tremor and disruption of the nigrostriatal dopaminergic system: an 18F-dopa PET study.
    Brooks DJ; Playford ED; Ibanez V; Sawle GV; Thompson PD; Findley LJ; Marsden CD
    Neurology; 1992 Aug; 42(8):1554-60. PubMed ID: 1641153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in the reduced 18F-Dopa uptakes of the caudate and the putamen in Parkinson's disease: correlations with the three main symptoms.
    Otsuka M; Ichiya Y; Kuwabara Y; Hosokawa S; Sasaki M; Yoshida T; Fukumura T; Masuda K; Kato M
    J Neurol Sci; 1996 Mar; 136(1-2):169-73. PubMed ID: 8815166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study.
    Rinne JO; Portin R; Ruottinen H; Nurmi E; Bergman J; Haaparanta M; Solin O
    Arch Neurol; 2000 Apr; 57(4):470-5. PubMed ID: 10768619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FDG- and Dopa-PET in postencephalitic parkinsonism.
    Ghaemi M; Rudolf J; Schmülling S; Bamborschke S; Heiss WD
    J Neural Transm (Vienna); 2000; 107(11):1289-95. PubMed ID: 11145004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.
    Theisen F; Leda R; Pozorski V; Oh JM; Adluru N; Wong R; Okonkwo O; Dean DC; Bendlin BB; Johnson SC; Alexander AL; Gallagher CL
    Neuroimage Clin; 2017; 16():557-563. PubMed ID: 28971007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies.
    Nagano-Saito A; Kato T; Arahata Y; Washimi Y; Nakamura A; Abe Y; Yamada T; Iwai K; Hatano K; Kawasumi Y; Kachi T; Dagher A; Ito K
    Neuroimage; 2004 Jun; 22(2):553-61. PubMed ID: 15193583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nigrostriatal dysfunction in homozygous and heterozygous parkin gene carriers: an 18F-dopa PET progression study.
    Pavese N; Khan NL; Scherfler C; Cohen L; Brooks DJ; Wood NW; Bhatia KP; Quinn NP; Lees AJ; Piccini P
    Mov Disord; 2009 Nov; 24(15):2260-6. PubMed ID: 19845000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regional striatal DOPA transport and decarboxylase activity in Parkinson's disease.
    Kuwabara H; Cumming P; Yasuhara Y; Léger GC; Guttman M; Diksic M; Evans AC; Gjedde A
    J Nucl Med; 1995 Jul; 36(7):1226-31. PubMed ID: 7790948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [18F]FDOPA PET and clinical features in parkinsonism due to manganism.
    Racette BA; Antenor JA; McGee-Minnich L; Moerlein SM; Videen TO; Kotagal V; Perlmutter JS
    Mov Disord; 2005 Apr; 20(4):492-496. PubMed ID: 15648057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Separating Parkinson's disease from normality. Discriminant function analysis of fluorodopa F 18 positron emission tomography data.
    Sawle GV; Playford ED; Burn DJ; Cunningham VJ; Brooks DJ
    Arch Neurol; 1994 Mar; 51(3):237-43. PubMed ID: 8129633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemi-parkinsonism in multiple system atrophy: a PET and MRI study.
    Kume A; Shiratori M; Takahashi A; Kato T; Ito K; Tadokoro M; Sakuma S
    J Neurol Sci; 1992 Jul; 110(1-2):37-45. PubMed ID: 1506867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nigral dysfunction in drug-induced parkinsonism: an 18F-dopa PET study.
    Burn DJ; Brooks DJ
    Neurology; 1993 Mar; 43(3 Pt 1):552-6. PubMed ID: 8451000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's disease.
    Ito K; Morrish PK; Rakshi JS; Uema T; Ashburner J; Bailey DL; Friston KJ; Brooks DJ
    J Neurol Neurosurg Psychiatry; 1999 Jun; 66(6):754-8. PubMed ID: 10329749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging.
    Ghaemi M; Hilker R; Rudolf J; Sobesky J; Heiss WD
    J Neurol Neurosurg Psychiatry; 2002 Nov; 73(5):517-23. PubMed ID: 12397143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.